Exposure to quadrivalent influenza vaccine during pregnancy: Results from a global pregnancy registry

BACKGROUND: The Fluzone® Quadrivalent (IIV4, Sanofi Pasteur) Pregnancy Registry was created to monitor vaccine safety during pregnancy (clinicaltrials.gov, NCT01945424). Here, we describe maternal, pregnancy, obstetrical and neonatal outcomes after vaccine exposure in pregnant women between August 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Ledlie, Shaleesa, Gandhi‐Banga, Sonja, Shrestha, Anju, Mallett Moore, Tamala, Khromava, Alena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692812/
https://www.ncbi.nlm.nih.gov/pubmed/34520127
http://dx.doi.org/10.1111/irv.12897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692812/
https://www.ncbi.nlm.nih.gov/pubmed/34520127
http://dx.doi.org/10.1111/irv.12897

Ejemplares similares